BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6287725)

  • 21. Autoimmunity in the Lambert-Eaton myasthenic syndrome.
    Lennon VA; Lambert EH; Whittingham S; Fairbanks V
    Muscle Nerve; 1982; 5(9S):S21-5. PubMed ID: 6302494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histochemical investigation of carcinoembryonic antigen in lung cancer].
    Shirakusa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Nov; 22(11):1004-11. PubMed ID: 6397653
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
    Tatsuno I; Konishi K
    Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
    [No Abstract]   [Full Text] [Related]  

  • 25. [Circulating immunocomplexes in the serum of female patients suffering with cancer of the uterine cervix (author's transl)].
    Vodvárka P; Willaschek J; Lochman I; Vrtná L
    Cesk Gynekol; 1982 May; 47(4):272-8. PubMed ID: 7094057
    [No Abstract]   [Full Text] [Related]  

  • 26. Loss of isoantigens A, B, and H in carcinoma of the lung.
    Davidsohn I; Ni LY
    Am J Pathol; 1969 Nov; 57(2):307-34. PubMed ID: 4902573
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
    Titscher R; Micksche M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():371-2. PubMed ID: 461311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
    Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical relevancy of cellular immunity in bronchogenic carcinoma].
    Muhrer KH; Filler D; Schwemmle K; Gierhake FW
    Prax Klin Pneumol; 1982 Aug; 36(8):335-9. PubMed ID: 7134160
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic studies in bronchogenic carcinoma.
    Zeromski J
    Ann Med Sect Pol Acad Sci; 1974; 19(3-4):197-236. PubMed ID: 4616524
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation, characterization, and biosynthesis of Forssman antigen in human lung and lung carcinoma.
    Yoda Y; Ishibashi T; Makita A
    J Biochem; 1980 Dec; 88(6):1887-90. PubMed ID: 6257673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody in sera of pulmonary cancer patients against specific surface antigen of oat cells.
    Oboshi S; Seido T; Tsugawa S
    Gan; 1971 Dec; 62(6):515-22. PubMed ID: 4334635
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic value of the tuberculin skin test as a parameter of cellular immunocompetence in cancer patients].
    Sone S; Ogushi F; Tsubura H; Fukuoka M
    Kekkaku; 1983 Oct; 58(10):559-62. PubMed ID: 6319794
    [No Abstract]   [Full Text] [Related]  

  • 37. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The natural history of bronchogenic carcinoma].
    Pozzi E
    Radiol Med; 1983 Sep; 69(9):682-6. PubMed ID: 6324291
    [No Abstract]   [Full Text] [Related]  

  • 39. [An evaluation of sputum cytology in the diagnosis of bronchogenic carcinoma].
    Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez MC; Gómez Serrano M; Toledo Aranjo AM
    Med Clin (Barc); 1982 Dec 1-31; 79(10):461-3. PubMed ID: 6296559
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunological diagnosis of bronchogenic carcinoma (author's transl)].
    Schlipköter HW; Idel H; Stiller-Winkler R
    Prax Klin Pneumol; 1982 Apr; 36(4):198-201. PubMed ID: 7048283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.